North America Insulin Pump Market Size, Share & Industry Trends Analysis Report

North America Insulin Pump Market Size, Share & Industry Trends Analysis Report By Product, By Disease Indication, By Distribution Channel (Retail & Online Pharmacies, and Hospital Pharmacy), By Country and Growth Forecast, 2023 - 2030


The North America Insulin Pump Market would witness market growth of 8.7% CAGR during the forecast period (2023-2030).

Diabetes patients can receive their prescribed amounts of insulin using insulin pumps, which are small, programmed medication delivery systems. The widespread adoption of insulin pumps has been facilitated by their increasing effectiveness in regularly treating and controlling diabetes by delivering consistent and timely insulin doses to patients.

The demand of insulin pumps over conventional techniques is accelerating, and technical advancements are the key reasons positively impacting market growth. For those who need to inject many doses of insulin daily, insulin pumps are quite practical. Since these devices are less invasive, a larger portion of the patient uses them. The rising senior population, rising diabetes occurrence, and rising obesity prevalence are mostly to blame for the market's expansion.

According to data released by the CDC, 37.3 million Americans (11.3 percent of the population) had diabetes in June 2022. More than one in three Americans, or 96 million adults, have prediabetes. Cardiovascular disease, type 2 diabetes, and stroke risk are all increased by prediabetes. As per the Economic Cost of Diabetes study by the American Diabetes Association, the total cost of diabetes diagnoses in the United States in 2017 was $327 billion. Increased incidence of diabetes and the expansion of government initiatives for its prevention and management, the market in North America is anticipated to expand.

The US market dominated the North America Insulin Pump Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,589 million by 2030. The Canada market is showcasing a CAGR of 11.2% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 10.2% during (2023 - 2030).

Based on Product, the market is segmented into Pumps (Tethered, Patch, and Others), and Consumables. Based on Disease Indication, the market is segmented into Type 1 Diabetes, and Type 2 Diabetes. Based on Distribution Channel, the market is segmented into Retail & Online Pharmacies, and Hospital Pharmacy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed AG, Aetna, Inc. (CVS Pharmacy, Inc.), SOOIL Developments Co., Ltd, Diabeloop SA, Jiangsu Delfu Medical Device Co.,Ltd, and APEX Medical Corporation

Scope of the Study

Market Segments covered in the Report:

By Product
  • Pumps
  • Pumps
  • Consumables
  • Consumables
By Disease Indication
  • Type 1 Diabetes
  • Type 2 Diabetes
By Distribution Channel
  • Retail & Online Pharmacies
  • Hospital Pharmacy
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Medtronic PLC
  • F. Hoffmann-La Roche Ltd.
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • Ypsomed AG
  • Aetna, Inc. (CVS Pharmacy, Inc.)
  • SOOIL Developments Co., Ltd
  • Diabeloop SA
  • Jiangsu Delfu Medical Device Co.,Ltd
  • APEX Medical Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Insulin Pump Market, by Product
1.4.2 North America Insulin Pump Market, by Disease Indication
1.4.3 North America Insulin Pump Market, by Distribution Channel
1.4.4 North America Insulin Pump Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trials and Approvals
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Feb – 2023, Mar) Leading Players
Chapter 4. North America Insulin Pump Market by Product
4.1 North America Pumps Market by Country
4.2 North America Insulin Pump Market by Pumps Type
4.2.1 North America Tethered Market by Country
4.2.2 North America Patch Market by Country
4.2.3 North America Others Market by Country
4.3 North America Consumables Market by Country
Chapter 5. North America Insulin Pump Market by Disease Indication
5.1 North America Type 1 Diabetes Market by Country
5.2 North America Type 2 Diabetes Market by Country
Chapter 6. North America Insulin Pump Market by Distribution Channel
6.1 North America Retail & Online Pharmacies Market by Country
6.2 North America Hospital Pharmacy Market by Country
Chapter 7. North America Insulin Pump Market by Country
7.1 US Insulin Pump Market
7.1.1 US Insulin Pump Market by Product
7.1.1.1 US Insulin Pump Market by Pumps Type
7.1.2 US Insulin Pump Market by Disease Indication
7.1.3 US Insulin Pump Market by Distribution Channel
7.2 Canada Insulin Pump Market
7.2.1 Canada Insulin Pump Market by Product
7.2.1.1 Canada Insulin Pump Market by Pumps Type
7.2.2 Canada Insulin Pump Market by Disease Indication
7.2.3 Canada Insulin Pump Market by Distribution Channel
7.3 Mexico Insulin Pump Market
7.3.1 Mexico Insulin Pump Market by Product
7.3.1.1 Mexico Insulin Pump Market by Pumps Type
7.3.2 Mexico Insulin Pump Market by Disease Indication
7.3.3 Mexico Insulin Pump Market by Distribution Channel
7.4 Rest of North America Insulin Pump Market
7.4.1 Rest of North America Insulin Pump Market by Product
7.4.1.1 Rest of North America Insulin Pump Market by Pumps Type
7.4.2 Rest of North America Insulin Pump Market by Disease Indication
7.4.3 Rest of North America Insulin Pump Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Tandem Diabetes Care, Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Trials and Approvals:
8.2 SOOIL Developments Co., Ltd
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.3 Jiangsu Delfu Medical Device Co.,Ltd
8.3.1 Company Overview
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Insulet Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Trials and Approvals:
8.6.5.3 Acquisition and Mergers:
8.6.5.4 Geographical Expansions:
8.7 Ypsomed AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.8 Aetna, Inc. (CVS Pharmacy, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.9 Diabeloop SA
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. APEX Medical Corporation
8.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings